ES2150052T3 - Forma cristalina de cefuroxima axetil biodisponible. - Google Patents

Forma cristalina de cefuroxima axetil biodisponible.

Info

Publication number
ES2150052T3
ES2150052T3 ES96109665T ES96109665T ES2150052T3 ES 2150052 T3 ES2150052 T3 ES 2150052T3 ES 96109665 T ES96109665 T ES 96109665T ES 96109665 T ES96109665 T ES 96109665T ES 2150052 T3 ES2150052 T3 ES 2150052T3
Authority
ES
Spain
Prior art keywords
cefuroxyme
crystalline form
axetil
bioavailable
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96109665T
Other languages
English (en)
Inventor
Maurizio Zenoni
Mario Leone
Angelo Cattaneo
Leonardo Marsili
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ACS Dobfar SpA
Original Assignee
ACS Dobfar SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ACS Dobfar SpA filed Critical ACS Dobfar SpA
Application granted granted Critical
Publication of ES2150052T3 publication Critical patent/ES2150052T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

UNA FORMA CRISTALINA BIODISPONIBLE DE AXETILO DE CEFUROXIMA, OBTENIDA MEDIANTE TRATAMIENTO DEL AXETILO DE CEFUROXIMA CONOCIDO, EN FORMA CRISTALINA O AMORFA, CON AGUA O CON UN SOLVENTE ORGANICO MISCIBLE EN AGUA, O CON UNA MEZCLA DE AMBOS, A UNA TEMPERATURA DE ENTRE +20 C Y +100 C, SEGUIDO DE ENFRIAMIENTO Y SEPARACION DEL PRODUCTO CRISTALINO POR METODOS CONOCIDOS.
ES96109665T 1995-08-03 1996-06-17 Forma cristalina de cefuroxima axetil biodisponible. Expired - Lifetime ES2150052T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001716A IT1277426B1 (it) 1995-08-03 1995-08-03 Forma cristallina biodisponibile del cefuroxima axetil

Publications (1)

Publication Number Publication Date
ES2150052T3 true ES2150052T3 (es) 2000-11-16

Family

ID=11372130

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96109665T Expired - Lifetime ES2150052T3 (es) 1995-08-03 1996-06-17 Forma cristalina de cefuroxima axetil biodisponible.

Country Status (24)

Country Link
US (1) US5677443A (es)
EP (1) EP0757991B1 (es)
JP (1) JPH09104685A (es)
KR (1) KR970010776A (es)
CN (1) CN1055693C (es)
AR (1) AR003973A1 (es)
AT (1) ATE195126T1 (es)
BR (1) BR9603270A (es)
CA (1) CA2179359A1 (es)
DE (1) DE69609576T2 (es)
DK (1) DK0757991T3 (es)
ES (1) ES2150052T3 (es)
FI (1) FI962937A7 (es)
GR (1) GR3034663T3 (es)
IL (1) IL118822A (es)
IT (1) IT1277426B1 (es)
MX (1) MX9603110A (es)
PT (1) PT757991E (es)
RU (1) RU2155767C2 (es)
SI (1) SI0757991T1 (es)
TR (1) TR199600691A3 (es)
TW (1) TW413635B (es)
UA (1) UA46727C2 (es)
ZA (1) ZA965234B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725382B1 (fr) * 1994-10-05 1997-01-03 Commissariat Energie Atomique Polyazacycloalcanes, complexes tri-, tetra- ou pentaazamacrocycliques, procede de fabrication de ces polyazacycloalcanes substitues ou non et greffes sur un support et utilisations des polyazacycloalcanes
NZ299077A (en) * 1996-07-26 1998-06-26 Apotex Inc Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf
KR100401284B1 (ko) * 1997-06-03 2004-01-31 주식회사유한양행 1-브로모에틸 아세테이트의 제조방법
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (es) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
EP0937727B1 (de) * 1998-02-20 2002-01-30 Fako Ilaclari A.S. Verfahren zur Herstellung vom löslichen kristallinen Cefuroxim axetil
US6384213B1 (en) 1998-10-23 2002-05-07 Ranbaxy Laboratories Limited Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil
IN190849B (es) * 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
ITMI20011763A1 (it) * 2001-08-10 2003-02-10 Antibioticos Spa Processo di preparazione di cefuroxime axelite ad elevata purezza
ITMI20011925A1 (it) * 2001-09-14 2003-03-14 Antibioticos Spa Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino
CZ12993U1 (cs) * 2001-11-23 2003-02-10 Glaxo Group Limited Farmaceutický prostředek
JP2007517864A (ja) * 2004-01-09 2007-07-05 ハンミ ファーム． シーオー．， エルティーディー． セフロキシムアキセチル顆粒及びこの製造方法
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
US8900637B2 (en) * 2005-12-02 2014-12-02 Lupin Limited Stable taste masked formulations of cephalosporins
DE102006019619A1 (de) * 2006-04-25 2007-10-31 Grünenthal GmbH Kristalline Modifikation von Cefuroximaxetil
CN102417451B (zh) * 2011-12-20 2013-12-04 浙江国邦药业有限公司 一种合成（r，s）1-溴代乙基乙酸酯的制备方法
CN103717607A (zh) * 2012-09-12 2014-04-09 海南卫康制药(潜山)有限公司 头孢呋辛钠新晶型化合物及其组合物粉针
CN106554361B (zh) * 2016-09-30 2018-10-09 华北制药河北华民药业有限责任公司 一种头孢呋辛酯口服制剂的制备方法
CN115594583A (zh) * 2022-10-13 2023-01-13 浙江东盈药业有限公司（Cn） 一种1-溴乙基乙酸酯的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil

Also Published As

Publication number Publication date
CA2179359A1 (en) 1997-02-04
UA46727C2 (uk) 2002-06-17
EP0757991B1 (en) 2000-08-02
ITMI951716A1 (it) 1997-02-03
DK0757991T3 (da) 2000-09-04
DE69609576D1 (de) 2000-09-07
ZA965234B (en) 1997-03-06
ATE195126T1 (de) 2000-08-15
AU700214B2 (en) 1998-12-24
IT1277426B1 (it) 1997-11-10
AR003973A1 (es) 1998-09-30
FI962937L (fi) 1997-02-04
TR199600691A2 (xx) 1998-03-21
RU2155767C2 (ru) 2000-09-10
JPH09104685A (ja) 1997-04-22
CN1147516A (zh) 1997-04-16
PT757991E (pt) 2000-11-30
IL118822A (en) 1999-11-30
GR3034663T3 (en) 2001-01-31
SI0757991T1 (en) 2000-12-31
TW413635B (en) 2000-12-01
TR199600691A3 (tr) 1998-03-21
ITMI951716A0 (it) 1995-08-03
CN1055693C (zh) 2000-08-23
US5677443A (en) 1997-10-14
FI962937A7 (fi) 1997-02-04
KR970010776A (ko) 1997-03-27
AU6083396A (en) 1997-02-06
EP0757991A1 (en) 1997-02-12
FI962937A0 (fi) 1996-07-23
DE69609576T2 (de) 2001-01-04
MX9603110A (es) 1997-06-28
BR9603270A (pt) 1998-04-28
IL118822A0 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
ES2150052T3 (es) Forma cristalina de cefuroxima axetil biodisponible.
ITRM940209A0 (it) Procedimento in due stadi per la produzione di policarbonato termopla-stico.
ID27762A (id) Turunan-turunan propanol tersubstitusi aril, metoda produksinya, obat-obatan yang mengandung senyawa tersebut dan penggunaannya
CA2198247A1 (en) Ionene polymers containing biologically-active anions
DE69202006D1 (de) Angetriebener Trokar.
CA1004550A (en) Twin-hull ship for drilling in ice-covered waters
AU564952B2 (en) N,n-dimethylglycine ester of metronidazole
EP0622463A3 (en) Processes for culturing marine microalgae and producing docosahexaenoic acid using the same.
TR27902A (tr) Trifendioksazin bilesikleri, bunlarin üretilmesine mahsus usul ve bunlarin boyar madde olarak kullanilmasi.
YU228687A (en) Process for obtaining coloidic basis gel containing primicine and antibiotic
NO944536D0 (no) Nye krystallinske forbindelser og anvendelse av disse, samt polymerblandinger som omfatter forbindelsene
Chin Resistance is useless
ITTO940301A0 (it) Punta di trivellazione con tenuta frontale rigida perfezionata.
ITTO920045A1 (it) Macchina con linea di ritardo per il trattamento di oggetti postali.
DE68917906D1 (de) Heissverformte anisotrope Magnete und deren Herstellung.
Andersen et al. Antibiotics from marine organisms of the Gulf of California.
AU7772287A (en) Separation of diastereomers
FR2714639B1 (fr) Habitacle de cabriolet.
FR2669620B1 (fr) Nouveau procede de recuperation du cuivre dans les eaux residuaires industrielles en contenant.
MX9205887A (es) Procedimiento para incrementar el rendimiento de las bacterias capaces de segregar aminoacidos.
ITRM920520A1 (it) Granuli liofilizzati contenenti microorganismi fungini, e procedimento per la loro preparazione.
KR940020887A (ko) 원형 회전선반에 의한 다단식 버섯 재배 방법
ITGE930078A1 (it) Dispositivo di guida bloccabile.
JPS5224471A (en) Junction field effect transistor and its process
IT8211666U1 (it) Impermeabile e forma di piante, adatto per ciclisti e per altri impieghi.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 757991

Country of ref document: ES